[1]
2024. Pharmacogenomic Profiling Of The Saudi Population And Its Implications For Personalized Dosing Of Anticoagulants. The Review of Diabetic Studies . (Nov. 2024), 143–155. DOI:https://doi.org/10.70082/actjqe60.